Shandong Keyuan Pharmaceutical Co., Ltd. () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Shandong Keyuan Pharmaceutical Co., Ltd.

Why is Shandong Keyuan Pharmaceutical Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of -0.59% and Operating profit at -34.33% over the last 5 years

The company has declared Negative results for the last 5 consecutive quarters

NET PROFIT(HY) At CNY 16.3 MM has Grown at -62.72%
INTEREST(HY) At CNY 0.06 MM has Grown at 55.28%
ROCE(HY) Lowest at 1.7%

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Shandong Keyuan Pharmaceutical Co., Ltd. should be less than 10%
Overall Portfolio exposure to Specialty Chemicals should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Specialty Chemicals)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Shandong Keyuan Pharmaceutical Co., Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Shandong Keyuan Pharmaceutical Co., Ltd.

44.13%

2.77

52.31%

China Shanghai Composite

0.9%

1.20

14.07%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-0.59%

EBIT Growth (5y)

-34.33%

EBIT to Interest (avg)

50.83

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.24

Sales to Capital Employed (avg)

0.31

Tax Ratio

8.56%

Dividend Payout Ratio

32.70%

Pledged Shares

Institutional Holding

ROCE (avg)

9.18%

ROE (avg)

5.63%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

119

Industry P/E

Price to Book Value

2.11

EV to EBIT

99.15

EV to EBITDA

40.81

EV to Capital Employed

2.29

EV to Sales

6.10

PEG Ratio

Dividend Yield

0.04%

ROCE (Latest)

2.31%

ROE (Latest)

1.78%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

No Signal

Bollinger Bands

Mildly Bullish

Bullish

Moving Averages

Bullish (Daily)

KST

Mildly Bearish

Dow Theory

Mildly Bullish

Mildly Bearish

OBV

Mildly Bullish

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

23What is working for the Company

OPERATING CASH FLOW(Y)

Highest at CNY 64.33 MM

NET SALES(Q)

Highest at CNY 170.16 MM

OPERATING PROFIT(Q)

Highest at CNY 45.5 MM

PRE-TAX PROFIT(Q)

Highest at CNY 40.09 MM

NET PROFIT(Q)

Highest at CNY 34.48 MM

EPS(Q)

Highest at CNY 0.32

-15What is not working for the Company

INTEREST(HY)

At CNY 0.46 MM has Grown at 2,664.37%

NET PROFIT(9M)

At CNY 50.78 MM has Grown at -19.86%

DEBT-EQUITY RATIO (HY)

Highest at -9.39 %

DEBTORS TURNOVER RATIO(HY)

Lowest at 2.49 times

RAW MATERIAL COST(Y)

Grown by 7.51% (YoY

Here's what is working for Shandong Keyuan Pharmaceutical Co., Ltd.

Net Sales

At CNY 170.16 MM has Grown at 45.86%

Year on Year (YoY)

MOJO Watch

Near term sales trend is very positive

Net Sales (CNY MM)

Pre-Tax Profit

At CNY 40.09 MM has Grown at 121.4%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (CNY MM)

Operating Cash Flow

Highest at CNY 64.33 MM

in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Net Sales

Highest at CNY 170.16 MM

in the last five periods

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Operating Profit

Highest at CNY 45.5 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is positive

Operating Profit (CNY MM)

Pre-Tax Profit

Highest at CNY 40.09 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit

Highest at CNY 34.48 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

Net Profit

At CNY 34.48 MM has Grown at 75.59%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

EPS

Highest at CNY 0.32

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (CNY)

Here's what is not working for Shandong Keyuan Pharmaceutical Co., Ltd.

Interest

At CNY 0.46 MM has Grown at 2,664.37%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Debt-Equity Ratio

Highest at -9.39 % and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Debtors Turnover Ratio

Lowest at 2.49 times and Fallen

In each half year in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Raw Material Cost

Grown by 7.51% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales

Footer loading